新兴的纳米技术支持的siRNA口服输送平台
Angelea Maestas-Olguin1, Maya M Dawson2, Emily Rhoades Clark2
1Department of Chemical and Biological Engineering, University of New Mexico, Albuquerque, NM, USA.
Nanomedicine (London, England)
|December 6, 2025
概括
使用纳米技术口服小干扰RNA (siRNA) 克服了胃肠道障碍,从而有效地静止基因. 这种方法有望为患者提供友好的治疗方法,减少对侵入性方法的依赖.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 基因治疗 基因治疗
背景情况:
- RNA干扰 (RNAi) 使用小干扰RNA (siRNA) 进行序列特定的基因沉默.
- 纳米粒子平台已经使siRNA的临床静脉注射 (IV) 交付成为可能.
- 口服siRNA输送面临着显著的胃肠道 (GI) 生物障碍.
研究的目的:
- 审查口服siRNA输送的胃肠道障碍.
- 为突出纳米粒子平台的进步口服siRNA交付.
- 探索口服siRNA纳米药物的翻译方面.
主要方法:
- 关于口服纳米粒子和siRNA传递的文学综合评论.
- 在新墨西哥大学大学图书馆,科学网,谷歌学者和PubMed (2025年4月至11月) 进行的搜索.
- 专注于纳米粒子平台,siRNA装载的纳米粒子,基因疗法和纳米药物交付.
主要成果:
- 基于纳米技术的策略正在成为口服siRNA输送的解决方案.
- 最近的进展表明,在克服肠胃障碍方面有望实现有效的基因沉默.
- 口服siRNA纳米药物有可能减少亲肠道输送和单克隆抗体的使用.
结论:
- 口服siRNA纳米药物代表了一个有希望的,对患者友好的治疗策略.
- 这种方法可以显著减少对侵入性治疗的需求.
- 这些进展为临床上可行的口服siRNA疗法铺平了道路.
相关概念视频
siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
Drug Delivery: Overview
703
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
703
Microorganisms in Medicine and Therapeutics
917
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
917
RNA Interference
27.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K


